Lunati ME

Division of Endocrinology, ASST Fatebenefratelli Sacco, Milan Italy.

1 paper

ArticlePsilocybin

Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms.

Colognesi M, Gabbia D, Signor A +30